Ravindra Prasad Thokala: When T Cells Heal and Harm in the Same Transplant Unit
Ravindra Prasad Thokala, Transfusion Medicine Consultant and Head at Apollo Cancer Center, shared a post on LinkedIn:
“Two patients, two cell therapies, two opposite ends of the same immune system — and a striking reminder of why this cellular therapy is equal parts thrilling and humbling.
The first: adenovirus-specific T cells (CD4 and CD8) at a 5 million cell dose, prepared against refractory adenoviremia after a stem cell transplant, when the patient’s own reconstituting immunity and neither the list of antivirals simply cannot control the virus.
With turnaround — under 36 hours from leukapheresis to infusion (helped by Cytocare technologies for such a processing in the shortest time) — because in this race that speed can be the difference between staying ahead of the virus and forever chasing it.
The second: extracorporeal photopheresis for aggressive (fiery) acute skin GvHD, where the problem is the exact opposite — donor T cells that have turned on the patient’s own tissue, leaving the skin you see here.
Rather than simply suppressing those cells, photopheresis collects, treats and returns them in a way that tames the T cells gone rogue , same time gently retrains the immune response.
One therapy adds T cells to deliver might Against a virus; the other tames T cells that target the host — same cells, opposite missions, one shared goal of carrying a transplant patient safely through.
This is the reality of cellular therapy:
You would never wish either situation on a patient, but working in this space … you will eventually meet both.
Grateful to a team that can pivot between building immunity and calming it, sometimes on the very same day — and now we wait, watch and hope for both responses.”

Stay updated with Hemostasis Today.
-
Sep 22, 2026, 19:02Blocking Histone-Induced Platelet-Erythrocyte Interactions With Polyanions – Platelets Journal
-
Sep 22, 2026, 18:49Abdul Rahman Hamad: Early Action for Better Outcomes in Deep Vein Thrombosis
-
Sep 22, 2026, 18:37Carmine Siniscalchi: Age-Adjusted D-Dimer Cutoffs in DVT Diagnosis
-
Sep 22, 2026, 18:37Stefano Romeo: The Cardiovascular Patient Journey is Still Full of Gaps
-
Sep 22, 2026, 18:11Bharath Kumar V.։ Advancing Safer Anticoagulation for Cancer-Associated Thrombosis
-
Sep 22, 2026, 18:10Fatima Zahra: ASH Released New Guidelines on the Diagnosis of Iron Deficiency
-
Sep 22, 2026, 17:49Nirav Dhanesha: Targeting FXI for Safer Anticoagulation
-
Sep 22, 2026, 17:17Eric Lambert: Intravascular Imaging and the Future of Precision PCI
-
Sep 22, 2026, 16:45Claudiu Stoicescu: Are We Starting Cardiovascular Risk Assessment Too Late?